Treatment characteristics and mortality of a large insured female population with advanced or metastatic breast cancer by receipt of HER2-targeted agents
Comparative Effectiveness Research · 2015
DOI: 10.2147/cer.s73220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Comparative Effectiveness Research, 2015. Verfasst von Yanni Hao und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hao, Y., Meyer, N., Johnson, W., Rogerio, J. W., & Landsman-Blumberg, P. (2015). Treatment characteristics and mortality of a large insured female population with advanced or metastatic breast cancer by receipt of HER2-targeted agents. Comparative Effectiveness Research. https://doi.org/10.2147/cer.s73220
Vancouver
Hao Y, Meyer N, Johnson W, Rogerio JW, Landsman-Blumberg P. Treatment characteristics and mortality of a large insured female population with advanced or metastatic breast cancer by receipt of HER2-targeted agents. Comparative Effectiveness Research. 2015. doi:10.2147/cer.s73220
BibTeX
@article{Hao2015,
author = {Hao, Yanni and Meyer, Nicole and Johnson, William and Rogerio, Jaqueline Willemann and Landsman-Blumberg, Pamela},
title = {Treatment characteristics and mortality of a large insured female population with advanced or metastatic breast cancer by receipt of HER2-targeted agents},
journal = {Comparative Effectiveness Research},
year = {2015},
doi = {10.2147/cer.s73220}
}
EUVIMED